logo

[breadcrumb_custom]

BCLI’s 52-Week Rollercoaster: From $0.13 to $3.46 – What’s Next for Investors?

Brainstorm Cell Therapeutics, Inc. had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $3.46 on 03/31/23, while the lowest price during the same period was $0.13 on 10/31/23.

52-week price history of BCLI Stock

A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Brainstorm Cell Therapeutics, Inc.’s current trading price is -83.53% away from its 52-week high, while its distance from the 52-week low is 325.37%. The stock’s price range during this period has fluctuated between $0.13 and $3.46. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 1.66 million for the day, which was evidently higher than the average daily volume of 1.38 million over the last three months.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Financial Performance and Market Capitalization

Brainstorm Cell Therapeutics, Inc. (BCLI) has experienced a quarterly rise of 193.66% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 27.92M and boasts a workforce of 43 employees.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.2899, with a change in price of +0.4100. Similarly, Brainstorm Cell Therapeutics, Inc. recorded 1,984,928 in trading volume during the last 100 days, posting a change of +256.25%.

BCLI Stock Stochastic Average

The raw stochastic average for Brainstorm Cell Therapeutics, Inc. over the last 50 days is presently at 96.77%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 96.77%. Further, the company’s Stochastic %K and %D values for the last 20 days were 85.03% and 77.98%, respectively.

BCLI Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. Until today this year the stock’s price performance recorded an increase of 108.79%. However, over the last six months, the performance has been stronger by -41.27%. The price of BCLI increased 72.47% over the last 30 days. And in the last five days, it has surged by 71.22%.

On Key

Related Posts